Novo Nordisk A/S

NYSE: NVO · Real-Time Price · USD
52.44
1.49 (2.92%)
At close: Aug 15, 2025, 3:59 PM
56.05
6.88%
After-hours: Aug 15, 2025, 07:58 PM EDT

Novo Nordisk A/S Cash Flow Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
111.07B 104.61B 100.99B 94.72B 89.9B 89.28B 83.68B 75.31B 67.24B 61.13B 55.52B 52.83B 50.54B 49.34B 47.76B 46.18B 44.36B 42.86B
Depreciation & Amortization
16.01B 20.02B 19.11B 16.9B 17.28B 10.61B 9.41B 8.46B 7.97B 7.43B 7.36B 7.41B 6.72B 6.3B 6.03B 5.32B 6.1B 6.04B
Stock-Based Compensation
n/a n/a n/a 2.15B 2.15B 2.15B 2.15B 1.54B 1.54B 1.54B 1.54B 1.04B 1.04B 1.04B 1.04B 823M 823M 823M
Other Working Capital
-23.92B -19.57B -11.99B -9.08B 13.85B 733M -631M 11.81B -10.87B -2.76B 9.35B -4.88B 6.43B 5.2B 2.19B 2.42B 2.21B 6.38B
Other Non-Cash Items
-11.35B 21.46B 21.98B 14.49B -2.1B -21.59B -8.69B 13.79B 26.97B 17.71B 6.26B -202M -9.9B -3.21B -4.3B 4.51B 3.41B -1.59B
Deferred Income Tax
29.71B 27.69B 26.2B 24.53B 23.04B 22.58B 20.99B 18.06B 16.1B 14.75B 13.54B 13.03B 12.4B 11.72B 11.32B 11.79B 11.19B 11.18B
Change in Working Capital
-23.92B -19.57B -11.99B -20.7B 2.23B -10.88B -12.24B -2.87B -25.55B -17.45B -5.34B -15.72B -4.41B -5.64B -8.66B -1.94B -2.15B 2.02B
Operating Cash Flow
121.53B 131.25B 120.97B 118.22B 115.33B 93.41B 108.91B 106.46B 89.73B 85.11B 78.89B 68.77B 66.04B 67.33B 55B 58.19B 54.19B 53.19B
Capital Expenditures
-59.54B -56.5B -50.92B -50.8B -49.31B -43.1B -38.9B -28.63B -22.23B -17.77B -14.75B -10.89B -8.36B -7.67B -7.38B -17.98B -22.37B -21.86B
Cash Acquisitions
-81.49B -82.16B -82.16B 6.36B 11.16B 12.98B 14.94B 832M -2.97B -3.99B -5.68B -16.89B -17.37B -17.34B -17.5B 785M 272M 97M
Purchase of Investments
-9.49B -18.77B -19.81B -20.41B -16.8B -12.09B -13.29B -15.46B -12.33B -10.24B -9.73B -6.84B -8.27B -6.61B -7.11B -6.88B -3.76B -2.35B
Sales Maturities Of Investments
17.86B 18.29B 24.39B 19.87B 22.04B 21.9B 8.29B 8.14B 6.9B 5.43B 6.64B 4.35B 3.56B 2.53B 1.17B 951M 772M 369M
Other Investing Acitivies
-3.62B -11.6B 1.99B -4.58B -8.99B -552M -14.94B -9.72B -5.92B -4.9B -3.21B -1.67B -1.18B -1.22B -1.05B -777M -241M -194M
Investing Cash Flow
-133.04B -139.52B -128.9B -52.4B -44.73B -33.29B -43.89B -43.02B -34.74B -29.66B -24.92B -31.67B -31.34B -30.03B -31.61B -23.9B -25.33B -23.81B
Debt Repayment
39.62B 88.7B 73.06B 28.38B 28.53B -1.31B -1.47B -1.24B -1.31B -1.18B -2.41B 9.78B 9.94B 14.12B 15.47B 3.03B 3.06B -879M
Common Stock Repurchased
-11.28B -18.73B -20.18B -22.45B -26.19B -27.56B -29.92B -27.7B -26.18B -24.81B -24.09B -24.06B -22.97B -20.96B -19.45B -17.59B -17.04B -17.13B
Dividend Paid
-50.68B -50.86B -44.14B -44.14B -41.99B -41.99B -31.77B -31.77B -27.95B -27.95B -25.3B -25.3B -23.71B -23.71B -21.52B -21.52B -21.07B -21.07B
Other Financial Acitivies
n/a -13.06B -34.51B -34.51B -34.51B 1.94B n/a n/a n/a 656M n/a n/a n/a 408M n/a 5.68B 5.68B 5.86B
Financial Cash Flow
-22.34B 40.57B 8.73B -38.22B -39.65B -68.92B -63.16B -60.71B -55.44B -53.28B -51.8B -39.58B -36.75B -30.15B -25.49B -30.4B -29.36B -33.21B
Net Cash Flow
-34.39B 32.61B 1.26B 27.14B 31.25B -8.61B 1.74B 1.97B -1.18B 1.73B 1.93B -1.58B -1.47B 7.53B -1.51B 4.03B -624M -4.03B
Free Cash Flow
61.99B 74.74B 70.04B 67.42B 66.03B 50.3B 70.01B 77.83B 67.5B 67.34B 64.13B 57.88B 57.68B 59.66B 47.62B 40.21B 31.81B 31.34B